Cancer Epidemiology Biomarkers & Prevention, Vol 5, Issue 12 979-983, Copyright © 1996 by American Association for Cancer Research

ARTICLES

The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts

N Rothman, RB Hayes, TV Zenser, DM DeMarini, W Bi, A Hirvonen, G Talaska, VK Bhatnagar, NE Caporaso, LR Brooks, VM Lakshmi, P Feng, SK Kashyap, X You, BT Eischen, R Kashyap, ML Shelton, FF Hsu, M Jaeger, DJ Parikh, BB Davis, S Yin and DA Bell
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.

Multiple studies in the general population have suggested that subjects with the glutathione S-transferase M1 (GSTM1)-null genotype, who lack functional GSTM1, are at higher risk for bladder cancer. To evaluate the impact of the GSTM1-null genotype on bladder cancer caused by occupational exposure to benzidine and to determine its influence on benzidine metabolism, we carried out three complementary investigations: a case-control study of bladder cancer among workers previously exposed to benzidine in China, a cross-sectional study of urothelial cell DNA adducts and urinary mutagenicity in workers currently exposed to benzidine in India, and a laboratory study of the ability of human GSTM1 to conjugate benzidine and its known metabolites in vitro. There was no overall increase in bladder cancer risk for the GSTM1-null genotype among 38 bladder cancer cases and 43 controls (odds ratio, 1.0; 95% confidence interval, 0.4-2.7), although there was some indication that highly exposed workers with the GSTM1-null genotype were at greater risk of bladder cancer compared to similarly exposed workers without this allele. However, the GSTM1 genotype had no impact on urothelial cell DNA adduct and urinary mutagenicity levels in workers currently exposed to benzidine. Furthermore, human GSTM1 did not conjugate benzidine or its metabolites. These results led us to conclude that the GSTM1-null genotype does not have an impact on bladder cancer caused by benzidine, providing a contrast to its association with elevated bladder cancer risk in the general population.

This article has been cited by other articles:

				A. Beyerbach, N. Rothman, V. K. Bhatnagar, R. Kashyap, and G. Sabbioni Hemoglobin adducts in workers exposed to benzidine and azo dyes Carcinogenesis, August 1, 2006; 27(8): 1600 - 1606. [Abstract] [Full Text] [PDF]

				L. S. Engel, E. Taioli, R. Pfeiffer, M. Garcia-Closas, P. M. Marcus, Q. Lan, P. Boffetta, P. Vineis, H. Autrup, D. A. Bell, et al. Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review Am. J. Epidemiol., July 15, 2002; 156(2): 95 - 109. [Abstract] [Full Text] [PDF]

				L.E. Johns and R.S. Houlston Glutathione S-transferase {micro}1 (GSTM1) status and bladder cancer risk: a meta-analysis Mutagenesis, September 1, 2000; 15(5): 399 - 404. [Abstract] [Full Text] [PDF]

				Q. Lan, X. He, D. J. Costa, L. Tian, N. Rothman, G. Hu, and J. L. Mumford Indoor Coal Combustion Emissions, GSTM1 and GSTT1 Genotypes, and Lung Cancer Risk: A Case-Control Study in Xuan Wei, China Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 605 - 608. [Abstract] [Full Text]